318 related articles for article (PubMed ID: 26451906)
1. Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?
Komatani TS
Pharm Pat Anal; 2015; 4(5):357-62. PubMed ID: 26451906
[No Abstract] [Full Text] [Related]
2. Prometheus: the Supreme Court redefines the patentability of diagnostic inventions.
Kumamoto A; Schmid CL
Recent Pat DNA Gene Seq; 2012 Dec; 6(3):193-6. PubMed ID: 22812581
[TBL] [Abstract][Full Text] [Related]
3. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
Bergin C
Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
[TBL] [Abstract][Full Text] [Related]
4. Patentability of self-replicating technologies.
Shear RH
Cold Spring Harb Perspect Med; 2014 Sep; 5(1):a021071. PubMed ID: 25256175
[TBL] [Abstract][Full Text] [Related]
5. Mayo, Myriad, America Invents Act and BPCIA: how has the United States biopharmaceutical market been affected?
Finston SK; Davey NS; Davé E; Ravichandran V; Davey SR; Davé RS
Pharm Pat Anal; 2016 May; 5(3):159-67. PubMed ID: 27087460
[TBL] [Abstract][Full Text] [Related]
6. Patentability of Stem Cells in the United States.
Fendrick SE; Zuhn DL
Cold Spring Harb Perspect Med; 2015 Aug; 5(12):. PubMed ID: 26292987
[TBL] [Abstract][Full Text] [Related]
7. Patentability of genetically engineered microorganisms.
Cooper A
JAMA; 1983 Mar; 249(12):1553-4. PubMed ID: 6338261
[TBL] [Abstract][Full Text] [Related]
8. Bilski v. Kappos: the US Supreme Court broadens patent subject-matter eligibility.
Simmons WJ
Nat Biotechnol; 2010 Aug; 28(8):801-5. PubMed ID: 20697402
[No Abstract] [Full Text] [Related]
9. [U.S. Supreme Court ruling on patentability of genes].
Darío Bergel S
Rev Derecho Genoma Hum; 2013; (39):99-118. PubMed ID: 24868959
[TBL] [Abstract][Full Text] [Related]
10. Patent watch: US Supreme Court revises patent claim construction standards.
Noonan K
Nat Rev Drug Discov; 2015 Mar; 14(3):157. PubMed ID: 25722233
[No Abstract] [Full Text] [Related]
11. Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
Offit K; Bradbury A; Storm C; Merz JF; Noonan KE; Spence R
J Clin Oncol; 2013 Jul; 31(21):2743-8. PubMed ID: 23766521
[TBL] [Abstract][Full Text] [Related]
12. Patent watch: Supreme Court decision impacts the strength of US patents.
Brinckerhoff CC
Nat Rev Drug Discov; 2016 Jul; 15(8):524. PubMed ID: 27469227
[No Abstract] [Full Text] [Related]
13. US personalized-medicine industry takes hit from Supreme Court.
Ledford H
Nature; 2016 Aug; 536(7617):382. PubMed ID: 27558042
[No Abstract] [Full Text] [Related]
14. US Supreme Court rules on landmark gene patent case.
Sklan A
Pharm Pat Anal; 2013 Sep; 2(5):581. PubMed ID: 24237164
[No Abstract] [Full Text] [Related]
15. KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.
Bouchard RA
Health Law J; 2007; 15():247-94. PubMed ID: 19702185
[No Abstract] [Full Text] [Related]
16. US Patent Office issues guidelines on natural product patent eligibility.
Harrison C
Nat Rev Drug Discov; 2014 Apr; 13(4):250. PubMed ID: 24687057
[No Abstract] [Full Text] [Related]
17. The end of DNA patents in the United States?
Webber P
Expert Opin Ther Pat; 2013 Dec; 23(12):1525-7. PubMed ID: 24138004
[TBL] [Abstract][Full Text] [Related]
18. Three recent US patent decisions.
Kershen DL
GM Crops Food; 2013; 4(3):122-5. PubMed ID: 23970059
[No Abstract] [Full Text] [Related]
19. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions.
Pillai X; Kinney WA
Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Myriad on the Future Development and Commercialization of DNA-Based Therapies and Diagnostics.
Wales M; Cartier E
Cold Spring Harb Perspect Med; 2015 Sep; 5(12):. PubMed ID: 26337114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
